TScan Therapeutics, Inc. (TCRX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.00 | +12.3% |
| 2024 | $-1.14 | +16.2% |
| 2023 | $-1.36 | +50.5% |
| 2022 | $-2.75 | +34.1% |
| 2021 | $-4.17 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.00 | +12.3% |
| 2024 | $-1.14 | +16.2% |
| 2023 | $-1.36 | +50.5% |
| 2022 | $-2.75 | +34.1% |
| 2021 | $-4.17 | — |